- Home
- JDZG vs MYNZ Comparison
JDZG vs MYNZ Comparison
Compare JDZG & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- MYNZ
- Stock Information
- Founded
- JDZG 2020
- MYNZ 2021
- Country
- JDZG China
- MYNZ Germany
- Employees
- JDZG N/A
- MYNZ N/A
- Industry
- JDZG Other Consumer Services
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- JDZG Real Estate
- MYNZ Health Care
- Exchange
- JDZG Nasdaq
- MYNZ Nasdaq
- Market Cap
- JDZG 6.7M
- MYNZ 7.9M
- IPO Year
- JDZG 2024
- MYNZ 2021
- Fundamental
- Price
- JDZG $2.01
- MYNZ $1.46
- Analyst Decision
- JDZG
- MYNZ Buy
- Analyst Count
- JDZG 0
- MYNZ 2
- Target Price
- JDZG N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- JDZG 2.4M
- MYNZ 542.5K
- Earning Date
- JDZG 11-20-2025
- MYNZ 12-29-2025
- Dividend Yield
- JDZG N/A
- MYNZ N/A
- EPS Growth
- JDZG N/A
- MYNZ N/A
- EPS
- JDZG 0.25
- MYNZ N/A
- Revenue
- JDZG $2,567,741.00
- MYNZ $659,935.00
- Revenue This Year
- JDZG N/A
- MYNZ $26.06
- Revenue Next Year
- JDZG N/A
- MYNZ $4.97
- P/E Ratio
- JDZG $7.87
- MYNZ N/A
- Revenue Growth
- JDZG 20.36
- MYNZ N/A
- 52 Week Low
- JDZG $1.58
- MYNZ $1.28
- 52 Week High
- JDZG $14.00
- MYNZ $14.39
- Technical
- Relative Strength Index (RSI)
- JDZG 51.18
- MYNZ 42.18
- Support Level
- JDZG $1.72
- MYNZ $1.51
- Resistance Level
- JDZG $2.07
- MYNZ $1.63
- Average True Range (ATR)
- JDZG 0.23
- MYNZ 0.12
- MACD
- JDZG 0.00
- MYNZ 0.00
- Stochastic Oscillator
- JDZG 20.22
- MYNZ 29.03
About JDZG JIADE LIMITED Common stock
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.